X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.fiercepharma.com/manufacturing/paxlovid-production-pfizer-partners-chinese-company-huahai-which-coming-fda-ban
https://www.bnnbloomberg.ca/pfizer-picks-china-firm-involved-in-drug-recall-for-covid-pill-1.1809083
https://www.fiercepharma.com/pharma-asia/biocon-viatris-insulin-biosimilar-astrazeneca-china-performance-huahai-fda-warning-lift
https://www.fiercepharma.com/manufacturing/3-years-valsartan-recall-zhejiang-huahai-china-drug-manufacturer-fda-warning-letter
https://www.pharmacompass.com/pdf/news/zhejiang-huahai-pharma-receives-fda-warning-letter-1637048144.pdf
https://endpts.com/ema-fda-begin-reviewing-heartburn-medicines-for-carcinogen/
https://www.raps.org/news-and-articles/news-articles/2019/9/ema-begins-testing-heartburn-medicines-for-carcino
https://www.nbcnews.com/health/health-care/u-s-officials-worried-about-chinese-control-american-drug-supply-n1052376?cid=public-rss_20190912
https://www.raps.org/news-and-articles/news-articles/2019/8/ndea-and-ndma-impurities-another-indian-manufactu
https://www.bloomberg.com/news/articles/2019-06-18/fourth-carcinogen-discovered-in-heart-pills-used-by-millions
Market Place
Share 
